Plasmacytosis
ICD-10 D72.822 is a billable code used to indicate a diagnosis of plasmacytosis.
Plasmacytosis refers to an abnormal increase in the number of plasma cells in the blood or bone marrow. Plasma cells are a type of white blood cell that produces antibodies, and their proliferation can indicate various underlying conditions, including multiple myeloma, chronic inflammatory diseases, or infections. In cases of plasmacytosis, patients may present with symptoms related to the underlying cause, such as fatigue, bone pain, or recurrent infections due to compromised immune function. The condition can be associated with neutropenia, where there is a decrease in neutrophils, a type of white blood cell crucial for fighting infections. This can complicate the clinical picture, as patients may be at increased risk for infections. Additionally, disorders of the spleen, such as splenomegaly, can affect the production and regulation of blood cells, further complicating the diagnosis and management of plasmacytosis. Immunodeficiencies may also be present, as the overproduction of plasma cells can lead to a dysfunctional immune response, making it essential for healthcare providers to conduct thorough evaluations to determine the underlying cause and appropriate treatment.
Detailed lab results, patient history, and treatment plans.
Diagnosis and management of multiple myeloma or other plasma cell disorders.
Ensure comprehensive documentation of lab findings and clinical symptoms.
Pathology reports, imaging studies, and treatment response assessments.
Management of malignancies associated with plasmacytosis.
Document the relationship between plasmacytosis and cancer treatment outcomes.
Used to evaluate blood cell counts in patients suspected of having plasmacytosis.
Document the reason for the CBC and any relevant clinical findings.
Hematology specialists should ensure all lab results are clearly documented.
Plasmacytosis can be caused by various conditions, including multiple myeloma, chronic infections, and autoimmune diseases. Identifying the underlying cause is crucial for appropriate management.
